ORGANIZATION AND NATURE OF OPERATIONS

12 Months Ended

Mar. 31, 2012

Accounting Policies [Abstract]

Business Description and Basis of Presentation [Text Block]

NOTE 1 - ORGANIZATION AND NATURE OF OPERATIONS

Incorporation and history

Cadista Holdings Inc. (formerly Trigen Laboratories Inc.) was incorporated in the State of Delaware, United States in 1988.

Cadista Holdings Inc.’s subsidiaries are as follows:

Subsidiaries	Ownership
Jubilant Cadista Pharmaceuticals Inc.		100	%
Colvant Sciences Inc.(dissolved on March 31, 2011)		100	%

Jubilant Cadista Pharmaceuticals Inc. (formerly Cadista Pharmaceuticals Inc.), (also referred to as “Cadista Pharmaceuticals”) was incorporated in 1996 as a 100% subsidiary of Cadista Holdings Inc. Jubilant Pharma Pte Limited, a company incorporated in Singapore, acquired 64% shareholding in Cadista Holdings Inc. on June 30, 2005. Subsequently, Jubilant Pharma Pte Limited increased its ownership interest in Cadista Holdings Inc. to 75% through issuance of additional shares by Cadista Holdings Inc. During the years ended March 31, 2010 and 2009 Jubilant Pharma Pte Limited increased the stake in the Company to 82.38% through its United States based subsidiary Jubilant Life Sciences Holdings Inc. (“JLSH”). Jubilant Life Sciences Limited, hereinafter referred to as “Jubilant”, a company incorporated in India, is the ultimate parent company of each of Jubilant Pharma Pte Limited and Jubilant Life Sciences Holdings Inc.

During the year JLSH acquired the shares held by Jubilant Pharma Pte Limited and subsequently transferred the shares to Generic Pharmaceutical Holdings Inc., a 100% subsidiary of JLSH.

Cadista Holdings Inc., through its subsidiary, Jubilant Cadista Pharmaceuticals Inc., is primarily engaged in the business of development, manufacture and marketing of generic drugs in the United States. The Company’s manufacturing facility is located in Salisbury, Maryland.